XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jun. 26, 2020
Jun. 28, 2019
Cash flows from operating activities:    
Net (loss) income $ (312,446) $ 363,052
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities    
Depreciation and amortization 443,971 447,408
Goodwill impairment and asset write-downs 244,952 0
Deferred income taxes (66,003) 21,861
Share-based compensation expense 15,349 48,414
Net gain on sale of Healthcare Technologies 0 (139,165)
Changes in operating assets and liabilities:    
Accounts Receivable 356,436 (88,173)
Inventories (18,620) (37,133)
Prepayments and Other Current Assets (88,386) (33,586)
Accounts Payable (386,646) (178,468)
Accrued Expenses (305,980) (164,584)
Payments made to clients on contracts (42,824) (30,169)
Other operating activities 85,352 (1,270)
Net cash (used in) provided by operating activities (74,845) 208,187
Cash flows from investing activities:    
Purchases of property and equipment and other (298,716) (340,449)
Disposals of property and equipment 39,341 11,020
Proceeds from divestiture 0 293,711
Acquisition of certain businesses, net of cash acquired (16,734) (35,515)
Proceeds from governmental agencies related to property and equipment 23,550 16,200
Other investing activities 1,228 5,641
Net cash used in investing activities (251,331) (49,392)
Cash flows from financing activities:    
Proceeds from long-term borrowings 3,221,329 107,796
Payments of long-term borrowings (970,616) (372,168)
Net change in funding under the Receivables Facility 335,600 255,000
Payments of dividends (83,060) (81,305)
Proceeds from issuance of common stock 88,581 21,339
Repurchase of common stock (6,540) (50,000)
Other financing activities (89,050) (31,322)
Net cash provided by (used in) financing activities 2,496,244 (150,660)
Effect of foreign exchange rates on cash and cash equivalents 544 (3,105)
Increase in cash and cash equivalents 2,170,612 5,030
Cash and cash equivalents, beginning of period 246,643 215,025
Cash and cash equivalents, end of period 2,417,255 220,055
Supplemental Cash Flow Information    
Interest paid 254,800 248,300
Income taxes paid, net of refunds 30,300 137,400
Depreciation and amortization $ 443,971 $ 447,408